Globus Medical, Inc. Stock

Equities

GMED

US3795772082

Medical Equipment, Supplies & Distribution

Market Closed - Nyse 04:00:02 2024-04-23 pm EDT 5-day change 1st Jan Change
51.27 USD +0.04% Intraday chart for Globus Medical, Inc. -1.00% -3.79%
Sales 2024 * 2.48B Sales 2025 * 2.65B Capitalization 6.94B
Net income 2024 * 272M Net income 2025 * 407M EV / Sales 2024 * 2.42 x
Net cash position 2024 * 939M Net cash position 2025 * 1.44B EV / Sales 2025 * 2.07 x
P/E ratio 2024 *
29.2 x
P/E ratio 2025 *
17.1 x
Employees 5,000
Yield 2024 *
-
Yield 2025 *
-
Free-Float 82.18%
More Fundamentals * Assessed data
Dynamic Chart
1 day+0.04%
1 week-1.00%
Current month-4.42%
1 month+0.23%
3 months-6.08%
6 months+1.69%
Current year-3.79%
More quotes
1 week
49.94
Extreme 49.94
52.04
1 month
49.94
Extreme 49.94
54.16
Current year
49.94
Extreme 49.94
57.46
1 year
43.39
Extreme 43.385
62.88
3 years
43.39
Extreme 43.385
84.23
5 years
33.41
Extreme 33.41
84.23
10 years
17.45
Extreme 17.45
84.23
More quotes
Managers TitleAgeSince
Chief Executive Officer 59 15-05-03
Founder 58 03-02-28
Founder 57 03-02-28
Members of the board TitleAgeSince
Director/Board Member 62 19-04-30
Director/Board Member 64 19-12-10
Director/Board Member 79 15-08-27
More insiders
Date Price Change Volume
24-04-22 51.25 +1.79% 967,602
24-04-19 50.35 -0.79% 1,059,314
24-04-18 50.75 -0.88% 969,555
24-04-17 51.2 -1.14% 1,160,564
24-04-16 51.79 -0.06% 1,091,496

Delayed Quote Nyse, April 23, 2024 at 04:00 pm EDT

More quotes
Globus Medical, Inc. is a medical device company that develops and commercializes healthcare solutions with a focus on improving the quality of life of patients with musculoskeletal disorders. The Company offers a portfolio of differentiated technologies that are used to treat a variety of musculoskeletal conditions. Musculoskeletal Solutions consist primarily of implantable devices, biologics, accessories, and surgical instruments used in a range of spinal, orthopedic and neurosurgical procedures. Its spine products address the majority of conditions affecting the spine, including degenerative conditions, deformity, tumors, and trauma. It provides solutions that facilitate both open and minimally invasive surgery (MIS) techniques. It includes traditional fusion implants, such as pedicle screws and rod systems. Its orthopedic trauma solutions are designed to treat a variety of orthopedic fracture patterns and patient anatomies in the upper and lower extremities, as well as the hip.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
D+
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
16
Last Close Price
51.25 USD
Average target price
64.89 USD
Spread / Average Target
+26.61%
Consensus